CA3260916A1 - Composés hétéroaryles pour le traitement de la douleur - Google Patents

Composés hétéroaryles pour le traitement de la douleur

Info

Publication number
CA3260916A1
CA3260916A1 CA3260916A CA3260916A CA3260916A1 CA 3260916 A1 CA3260916 A1 CA 3260916A1 CA 3260916 A CA3260916 A CA 3260916A CA 3260916 A CA3260916 A CA 3260916A CA 3260916 A1 CA3260916 A1 CA 3260916A1
Authority
CA
Canada
Prior art keywords
pain
treatment
heteroaryl compounds
heteroaryl
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CA3260916A
Other languages
English (en)
Inventor
Mark Thomas Miller
Dennis James Hurley
Timothy Donald Neubert
Vijayalaksmi Arumugam
Sara Sabina Hadida Ruah
Jason McCartney
Jinglan Zhou
Jaclyn Chau
Robert Martin Demoret
Senait G. Ghirmai
Roman Askatovich Valiulin
Alexander Frederick KINTZER
David Robert Slochower
Kathleen Aertgeerts
Elizabeth Mary Beck
James Jun Bon MUI
Miranda Adele Wright
Ronald Marcellus Alphonsus Knegtel
Ewa Iwona Chudyk
Joanne Louise Pinder
James Dodd
Iain Simpson
Original Assignee
Vertex Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vertex Pharmaceuticals Inc filed Critical Vertex Pharmaceuticals Inc
Publication of CA3260916A1 publication Critical patent/CA3260916A1/fr
Pending legal-status Critical Current

Links

CA3260916A 2022-04-22 2023-04-21 Composés hétéroaryles pour le traitement de la douleur Pending CA3260916A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US63/333,875 2022-04-22

Publications (1)

Publication Number Publication Date
CA3260916A1 true CA3260916A1 (fr) 2023-10-26

Family

ID=

Similar Documents

Publication Publication Date Title
CA3256604A1 (fr) Composés hétéroaryles pour le traitement de la douleur
EP3781564A4 (fr) Composés pour le traitement d'un cancer
EP4139280A4 (fr) Composés pour le traitement de sras
EP4255401A4 (fr) Composés pour le traitement du sars
EP3952882A4 (fr) Oligosaccharides immuno-modulatoires de traitement de la douleur
HK40121923A (en) Heteroaryl compounds for the treatment of pain
HK40121920A (en) Heteroaryl compounds for the treatment of pain
HK40121919A (en) Heteroaryl compounds for the treatment of pain
CA3260916A1 (fr) Composés hétéroaryles pour le traitement de la douleur
AU2022231043A1 (en) Chaperonin-containing tcp-1 inhibitors for the treatment of cancer
HK40124203A (en) Compound for treatment of pain
CA3268988A1 (fr) Composé pour le traitement de la douleur
HK40081993A (en) Compounds for the treatment of covid-19
CA3272161A1 (fr) Composés de probénécide pour le traitement d'affections dermatologiques médiées par l'inflammasome
HK40119944A (en) Use of niraparib for the treatment of brain cancer
HK40117401A (en) Treatment of pain
HK40130651A (en) Treatment of opiod-induced pain
CA3274078A1 (fr) Traitement de la douleur induite par les opioïdes
AU2024396398A1 (en) Therapy for the treatment of multiple myeloma
HK40103416A (en) Use of link-tsg6 for the treatment of osteoarthritic pain
EP4313077A4 (fr) Combinaison pour le traitement d'une thromboinflammation
HK40116900A (en) Pharmaceutical compositions for the treatment of visceral pain
HK40109247A (en) Heteroaryl compounds useful in the treatment of cognitive disorders
HK40130315A (en) Therapeutic compounds
CA3276216A1 (fr) Composés thérapeutiques